Protein kinase C-d is activated during apoptosis, following proteolytic cleavage by caspase 3. Furthermore, overexpression of the catalytic kinase fragment of PKC-d induces the nuclear phenotype associated with apoptosis, though the molecular basis of this eect has not been determined. In these studies we have examined the role of PKC-d in the disassembly of the nuclear lamina at apoptosis. The nuclear lamina is disassembled during mitosis and apoptosis and mitotic disassembly involves hyperphosphorylation of lamin proteins by mitotic lamin kinases. During apoptosis, lamin proteins are degraded by caspase 6 and the contribution made by phosphorylation has not been proven. We show here that protein kinase C-d co-localized with lamin B during apoptosis and activation of PKC-d by caspase 3 was concomitant with lamin B phosphorylation and proteolysis. Inhibition of PKC-d delayed lamin proteolysis, even in the presence of active caspase 6, whilst inhibitors of mitotic lamin kinases were without eect. In addition recombinant human PKC-d was able to phosphorylate lamin B in vitro suggesting that its actions are direct and not via an intermediary kinase. We propose that PKC-d is an apoptotic lamin kinase and that ecient lamina disassembly at apoptosis requires both lamin hyperphosphorylation and caspase mediated proteolysis.
Introduction
Apoptosis, or programmed cell death, is the process by which unwanted cells are removed from the body, eciently and without loss of their cellular contents. Disregulation of apoptosis underlies a variety of pathologies including chronic in¯ammatory disease (Edwards and Hallett, 1997) and cancer (Williams, 1991) . Whilst the gross morphology of apoptosis has been clearly described (Kerr et al., 1972) , the biochemical events underlying these changes have not been fully characterized. A knowledge of these processes would help to identify potential targets for the therapeutic regulation of apoptosis.
One of the key aspects of the nuclear phase of apoptosis is the disassembly of the nuclear lamina (Kaufmann, 1989) , a complex of lamin intermediate ®lament proteins that underlies the nuclear membrane and interact with chromatin at speci®c sites known as matrix attachment regions (Moir et al., 1994) . Disassembly of the lamina precludes any further attempts to replicate or repair DNA and is required for packaging of the nuclear material into apoptotic bodies. Lamin proteins are cleaved during apoptosis by the cysteine protease caspase 6 (Orth et al., 1996) and this has been proposed as the main mechanism for lamina disassembly. However, the lamina is an intricate network of proteins (Hozak et al., 1995) and we reasoned that an additional mechanism may be required to relax the lamina structure and provide access for caspase 6. Lamin phosphorylation could provide such a mechanism. Lamins are phosphoproteins and during mitosis, when the lamina is disassembled to allow separation of replicated chromosomes, lamins are hyperphosphorylated by mitotic lamin kinases to eect lamina disassembly (Peter et al., 1990) . Phosphorylation of lamin proteins during apoptosis has been described and both the mitotic lamin kinase p34 cdc2 (Shi et al., 1993) and protein kinase C-a (Shimizu et al., 1998) have been proposed to mediate phosphorylation. However, involvement of p34 cdc2 has since been ruled out by several authors (Norbury et al., 1994) and PKC-a is also an unlikely apoptotic lamin kinase as the literature concerning this PKC isoenzyme consistently indicate that it has an anti-apoptotic function (Lee et al., 1996; Yazaki et al., 1996; Whelan and Parker, 1998) .
In this study we have investigated an alternative candidate for the role of apoptotic lamin kinase, namely PKC-d. PKC-d is activated by caspase 3 proteolysis during apoptosis (Emoto et al., 1995) and overexpression of the 40 kD active proteolytic fragment of PKC-d is sucient to induce apoptosis in HeLa cells (Ghayur et al., 1996) . Furthermore, recent studies indicate that key substrates for PKC-d may reside in the nucleus (Bharti et al., 1998) and our earlier studies had shown that an activator of PKC-d, bistratene A, translocated PKC-d to the nucleus and the immunostaining was reminiscent of lamin proteins (Griths et al., 1996) . We show here that PKC-d was localized to the nuclear lamina during ara-C induced apoptosis in HL60 cells and that activation of PKC-d was coincident with lamin phosphorylation and proteolysis. Importantly, inhibition of PKC-d inhibited lamin phosphorylation and proteolysis, in the presence of active caspase 6. We therefore propose that both lamin phosphorylation and proteolysis are required for ecient lamina disassembly at apoptosis and that PKC-d, activated by caspase 3, is an apoptotic lamin kinase.
Results
To con®rm that substrates for PKC-d during apoptosis are likely to include nuclear proteins, we ®rst examined PKC-d localization using immunohistochemistry and confocal microscopy in viable HL60 cells and cells treated with ara-C to induce apoptosis. In nonapoptotic cells PKC-d, represented by green¯uores-cence, was detected primarily in the cytosol ( Figure  1a ). In contrast, during ara-C-induced apoptosis, PKCd was present at a high level in the nucleus, as indicated by overlapping of green (PKC-d)¯uorescence with the red nuclear counterstain, to produce yellow pseudo-color (Figure 1b) . Furthermore, staining within the nucleus was patchy, with several intense foci. Similar immunostaining was seen whether HL60 cells were induced in to apoptosis by UV-irradiation, TNFa treatment or died spontaneously in culture (data not shown). To ensure that this localisation pattern was not an immunostaining artefact, cells were transfected with the GFP-tagged active catalytic fragment of PKCd (Bharti et al., 1998) . Our results con®rm that the caspase generated fragment of PKC-d localized to the nucleus (Figure 1c) . GFP vector alone was distributed evenly throughout the cell (data not shown).
Translocation of PKC from the cytosol to a membrane location is an indicator of enzyme activation. Nuclear translocation of PKC-d revealed by immunostaining was con®rmed by subcellular fractionation of HL60 cells undergoing ara-C induced apoptosis (Figure 1d ). Full length 78 kD PKC-d translocated to the nucleus during ara-C induced apoptosis (Figure 1d ) and densitometric analysis revealed that almost half of total PKC-d (43+3.9%) was associated with the nuclear fraction after 3 h, compared with 21+2.4% in control cells. Nuclear translocation of PKC-d occurred prior to the development of an apoptotic morphology or Annexin V binding (Figure 1e ). The activity status of nuclear PKC-d was con®rmed by subcellular fractionation and detection of phosphorylation of PKC-d at threonine 505 (Good et al., 1998) using a phosphoT505 antibody (data not shown). As PKC-a has been suggested to be the mediator of lamin phosphorylation in camptothecin induced apoptosis in HL60 cells (Shimizu et al., 1998) , we determined whether other PKC isoenzymes expressed in HL60 cells were also activated during apoptosis. PKCa was present only in the cytosol in control cells. Some PKC-a was detected in the nucleus of ara-C treated cells after 3 h, though this accounted for only 4.5+0.5% of total PKC-a. Nuclear translocation of this PKC isoenzyme was more signi®cant after 6 h of treatment (Figure 1d ), when apoptosis was already underway in the majority of cells. Translocation of PKC-b I or b II was not detected in these studies (Figure 1d ). Nuclear translocation of PKC-d is thus an early event in ara-C induced apoptosis and has also been reported during cytokine deprivation and Fas-induced apoptosis in T cells (ScheelToellner et al., 1999) .
Further studies were performed to establish the signi®cance of nuclear translocation of full length PKC-d, in particular the relationship with the generation of the pro-apoptotic 40 kD fragment by caspase 3. The results show that nuclear translocation of full length PKC-d slightly preceded its cleavage by caspase 3, which was not detected until 4 h of ara-C treatment (Figure 2a, upper panel) . At these early time points the fraction of total cellular PKC-d cleaved by caspase 3 was relatively small and a signi®cant loss of immunoreactive 78 kD PKC-d occurred slightly later, i.e. 8 ± 9 h (data not shown). The PKC-d speci®c inhibitor Rottlerin (Gschwendt et al., 1994) delayed the appearance of the 40 kD catalytic fragment of PKC-d (Figure 2a , lower panel). As translocation is associated with PKC activation, Rottlerin will also prevent nuclear translocation of PKC-d (Chen et al., 1999) . These data therefore indicate that activation and/or nuclear translocation of full length PKC-d was a pre-requisite for caspase mediated proteolysis. Subcellular fractionation of ara-C treated HL60 cells also revealed that the 40 kD fragment was only detected in the nuclear fraction in the early stages of apoptosis (4 h), though it was detected in the cytosol fraction at later stages, after 6 h of ara-C treatment ( Figure 2b ). This con®rms that the initial targets of caspase 3 activated PKC-d are nuclear.
The immunolocalisation of PKC-d seen in ara-C treated cells (Figure 1b ) was reminiscent of nuclear lamin protein staining. We have reported this staining pattern previously for HL60 cells treated with a selective activator of PKC-d, Bistratene A (Griths et al., 1996) and during apoptosis of activated T cells (Scheel-Toellner et al., 1999) . To determine whether activated PKC-d was co-localized with lamin protein, ara-C treated HL60 cells were dual-immunostained with antibodies to lamin B (Figure 3 , left panel) and PKC-d (Figure 3 , centre panel) and species speci®c secondary antibodies conjugated to rhodamine and uorescein, respectively. Confocal microscopy revealed that PKC-d immunostaining co-localized (indicated by yellow pseudo-colour) with lamin B at the nuclear periphery and at discrete sites within the nucleus ( PO 4 and treated with ara-C to induce apoptosis. At time points up to 6 h cells were lysed and lamin B was immunoprecipitated. The results showed that a signi®cant increase in phosphorylation of lamin B was detected after 4 h of ara-C treatment ( Figure 4b ) and was further increased up to 6 h. Proteolysis of lamin B by caspase 6, to generate a characteristic 46 kD fragment (Orth et al., 1996) , was also measured in parallel extracts. Lamin proteolysis was ®rst detected after 4 h (Figure 4c ). Lamin phosphorylation and proteolysis were therefore coincident with the generation of the 40 kD fragment of PKC-d (Figure 1d) .
To determine the relevance of PKC-d activity to lamin phosphorylation and proteolysis, the PKC-d inhibitor Rottlerin was included in cultures prior to ara-C treatment. Rottlerin inhibited lamin phosphorylation ( Figure 4d ) and signi®cantly delayed the appearance of the 46 kD lamin fragment (Figure 4e ). An inhibitor of classical PKC isoenzymes (a,b,g), Go6976, was unable to block either lamin phosphorylation (Figure 4d ) or proteolysis (Figure 4e ), ruling out these isoenzymes as apoptotic lamin kinases. The involvement of the mitotic lamin kinase p34 cdc2 in lamina disassembly during apoptosis was also eliminated, as Olomoucine, an inhibitor kinase p34 cdc2 , also had no eect on lamin phosphorylation or degradation. Taken together, these data show that PKC-d was activated during the early stages of ara-C induced apoptosis and translocated to the nucleus, prior to its cleavage by caspase 3. Lamin phosphorylation occurred concomitant with the caspase 3 mediated generation of the 40 kD catalytic fragment of PKC-d and lamin proteolysis. As lamins are cleaved by caspase 6, it was important to establish whether the lack of lamin degradation seen in the presence of Rottlerin, was not due to absence of caspase activity. Measurement of caspase 6 activity showed that the delay to lamin proteolysis eected by the PKC-d inhibitor occurred in the presence of active caspase 6 (Figure 4f ). Thus caspase 6 activity alone is insucient for rapid lamina disassembly. To con®rm that PKC-d was able to phosphorylate lamin B directly and was not inducing lamin phosphorylation indirectly, recombinant human PKCd (Calbiochem-Novabiochem) was incubated with lamin B immunoprecipitated from healthy HL60 cells. Figure 5a shows that PKC-d was able to phosphorylate lamin B in vitro. In preliminary experiments to determine whether the sites on lamin B phosphorylated by PKC-d could be the same as those regulated by PKC-bII during mitosis, recombinant human PKC-d and PKC-bII were incubated with synthetic peptides spanning the known PKC sensitive sites in lamin B (389 ± 410). PKC-bII phosphorylated the peptide eciently (Figure 5b ) and phosphorylation was almost completely ablated in peptide containing mutations of the PKC-bII sites (S395A and S405A). PKC-d also phosphorylated the peptide containing the lamin B sequence, but phosphorylaton was not reduced in the mutant peptide (Figure 5b ). These data suggest that PKC-d may phosphorylate lamin B at sites distinct from those aected by PKC-bII.
As PKC, speci®cally PKC-bII, has been shown to phosphorylate lamin B at mitosis (Hocevar et al., 1993) we investigated whether PKC-d was also involved in the regulation of the nuclear lamina during cell cycle. HL60 cells were separated into the dierent stages of the cell cycle by centrifugal elutriation and the activity of PKCbII and d determined in cells at G1, S or G2/M by assessing the proportion of PKC in the particulate fraction by Western blotting. The results (Figure 6 ) con®rmed that PKC-bII was most active at G2/M. In contrast, the subcellular localisation of PKC-d was unchanged through the cell cycle ( Figure 6 ). These data indicate that PKC-d does not play a role in the regulation of cell cycle progression per se and we conclude that PKC-d has a speci®c role as an apoptotic lamin kinase.
Discussion
In our experiments we show that both proteolysis and phosphorylation of lamin proteins occurred during ara-C induced apoptosis in HL60 cells. Caspase 6 has already been identi®ed as the protease responsible for lamin degradation (Orth et al., 1996) and we show here that PKC-d activity is required for lamin phosphorylation. Phosphorylation of lamin proteins has been accepted as the eector of lamina disassembly during mitosis (Peter et al., 1990) , but the role of lamin phosphorylation during apoptosis has not been resolved. Our data show that if lamin phosphorylation is inhibited, then lamin degradation is delayed, but is not inhibited altogether. The nuclear lamina is a complex of proteins interacting in a meshwork that extends throughout the nucleus (Hozak et al., 1995) and it is likely that some relaxation of this structure would be required to ensure the very rapid dismantling of the lamina that occurs in apoptosis. This could be achieved by lamin phosphorylation. The role of the apoptotic lamin kinase would essentially be to increase the rate of lamina disassembly, rather than be an absolute requirement for this process. We propose that caspase 3 activated PKC-d is the apoptotic lamin kinase. Moreover, as both pro-caspase 6 (Srinvasula et al., 1996) and PKC-d (Ghayur et al., 1996) are substrates for caspase 3, the activation of caspase 3 at the initiation of the execution phase of apoptosis would ensure the simultaneous activation of the two enzymes required to eciently disassemble the nuclear lamina.
PKC-d is an attractive candidate for the apoptotic lamin kinase for many reasons. It is expressed in all cells (Hug and Sarre., 1993) and has long been suspected as having an important`housekeeping' function. It is activated during apoptosis induced by a wide variety of stimuli, including ionizing irradiation (Emoto et al., 1995) and ara-C (Ghayur et al., 1996) and its known substrates include other intermediate ®laments as well as nuclear matrix proteins. DNA-dependent protein kinase (DNA-PK), which is involved in DNA repair and located at the nuclear matrix, was identi®ed recently as a substrate for PKC-d (Bharti et al., 1998) . However, the catalytic fragment of PKC-d still homed to the nucleus in DNA-PK negative cells and was able to increase apoptosis, though at a reduced level compared to cells expressing DNA-PK. Other nuclear matrix substrates must therefore exist for PKC-d and contribute to its proapoptotic functions. Our data show that the nuclear lamina itself is a substrate for PKC-d. Characterization of the precise residues in lamin B phosphorylated by PKC-d is beyond the scope of this preliminary report. However, PKC-mediated phosphorylation of lamin B is known to be restricted to a domain within the carboxy terminus (Hocevar et al., 1993) . When PKC-d was incubated with synthetic peptide spanning this domain it was able to induce substantial phosphorylation of the peptide. However, unlike PKC-bII, peptide phosphorylation was not dependent on serine residues 395 and 405. Thus PKC-d may phosphorylate sites within lamin B in vivo that are distinct from those aected by the mitotic lamin kinase PKC-bII (Hocevar et al., 1993) . Studies are now ongoing to con®rm this hypothesis.
Our data revealed that full length PKC-d translocated to the nucleus prior to cleavage by caspase 3. We have shown previously that the initial translocation of full length PKC-d occurs during T cell apoptosis and can be reversed by interferon-b (Scheel-Toellner et al., 1999) . This event is therefore not part of the ®nal execution phase and may represent a pre-commitment step that localizes PKC-d to the nucleus. Furthermore, the protein tyrosine kinase c-abl has been shown to be activated by DNA damaging agents during apoptosis. C-abl is associated with PKC-d constitutively and phosphorylates PKC-d upon activation, resulting in translocation to the nucleus . Involvement of PKC-d is therefore a two stage process, requiring nuclear translocation and cleavage by caspase 3. Interestingly, activation of the oncogene product vabl is associated with activation and nuclear translocation of PKC-b II and prevention of apoptosis (Evans et al., 1995) . The activation of PKC-b by v-abl, as opposed to PKC-d by c-abl, may therefore be a key element of its oncogenic function.
In summary, we have shown that rapid disassembly of the nuclear lamina during apoptosis involves both phosphorlyation and proteolysis of lamin protein. The co-ordination of these events is assured as both enzymes involved, caspase 6 and PKC-d, are activated by caspase 3.
Materials and methods
Induction and assessment of apoptosis HL60 cells were cultured in RPMI 1640 medium containing 10% fetal calf serum and antibiotics. To induce apoptosis HL60 cells were incubated with 10 mM ara-C (Sigma, Poole, Dorset, UK) and apoptosis was assessed by analysis of Annexin V binding using a commercial kit (R & D systems, Abingdon, UK) at hourly intervals. In studies involving inhibitors of PKC, Go6976 and Rottlerin (CalbiochemNovabiochem, Nottingham, UK) or the p34 cdc2 inhibitor olomoucine (Calbiochem), these compounds were included in the incubation medium, at the concentrations shown, 30 min prior to ara-C treatment.
Indirect immunostaining for PKC-d and lamin B
For analysis of PKC-d and lamin localization cells were indirectly immunostained as cytospins, after ®xation in icecold acetone. To ensure complete access of lamin antibody to the nuclear matrix, the antibody was diluted in PBS containing 0.02% Tween-20 (PBT) and all washes were performed with PBT. Primary antibodies were anity puri®ed and raised against peptides in sheep for PKC-d (The Binding Site Ltd, Birmingham, UK) and rabbit for lamin proteins (kind gift from Dr N Chaudhary, RPI Ltd, Co, USA). Anti-rabbit IgG-Rhodamine conjugated (Dako Ltd, UK) and anti-sheep IgG-FITC conjugated (The Binding Site Ltd) were used as secondary antibodies. Fluorescence was visualized using a confocal microscope (MRC 500, BioRad).
Detection of proteolytic fragments of PKC-d and lamin B
For detection of PKC-d cells were lysed (Griths et al., 1996) and spun at 800 g for 10 min to sediment nuclei, then further centrifuged at 100 000 g for 45 min to isolate the membrane (pellet) and cytosol (supernatant) fractions. Each fraction was taken up in laemmli SDS sample buer and heated for 5 min at 1008C. For lamin analysis, cells were taken up directly in Laemmli buer. Proteins were separated on 10% SDS ± PAGE gels and transferred to PVDF membrane. Membranes were probed with rabbit antibodies to PKC-d, to an epitope in the carboxy terminus (Santa Cruz Biotechnology Inc., CA, USA), or lamin B (Dr N Chaudhary) and anti-rabbit IgG HRP conjugated secondary antibodies (Amersham International plc, Amersham, Bucks., UK). Immunoreactive bands were visualized by ECL detection (Amersham) and quanti®ed by scaning densitometry (LKB ultroscan).
Assessment of PKC isoenzyme activation during cell cycle
HL60 cell cultures in exponential growth were separated into three fractions, containing cells in G1, S and G2/M, by centrifugal elutriation (Mikulitis et al., 1997) . Cell cycle status was con®rmed by staining cells with propidium iodide and FACS analysis. Cells in each stage of the cell cycle were lysed and spun at 100 000 g for 45 min to isolate the cytosol and membrane fractions. PKC translocates from the cytosol to the membrane fraction upon activation. Proteins from each fraction were extracted in laemmli buer and immunoblot analysis performed as described above. Membranes were probed for PKC-a, bI, bII and d using monoclonal antipeptide antibodies (Santa Cruz) and anti-mouse IgG HRP conjugated (Santa Cruz) secondary antibodies. Blots were scanned densitometrically (LKB Ultrascan) and the relative distribution of each PKC between the cytosol and membrane determined.
Transfection with PKC-d constructs
HL60 cells were transiently transfected by electroporation (Gene pulsar, BioRad, 0.25 mV, 960 microfarads) in the presence of 1.25% DMSO (Melkonyan et al., 1996) with plasmids encoding the GFP-tagged cDNA for the caspase generated catalytic fragment of PKC-d (Bharti et al., 1998 ; amino acids 331 ± 676, construct provided by Dr R Datta, Harvard) or GFP-tagged vector alone. The expression of 40 kD PKC-d was detected 24 ± 36 h after transfection and con®rmed by confocal microscopy. Propidium iodide was added to cells prior to microscopy to identify cells in late apoptosis and allow visualization of DNA.
Detection of lamin B phosphorylation
HL60 cells were labelled for 4 h in phosphate free RPMI 1640 medium containing 1% FCS and 0.25 mCi/ml 32 Porthophosphate (Amersham) prior to treatment with ara-C. At the time points shown cells were washed in phosphate free medium and lysed in 20 mM Tris-HCl, pH 7.4 containing 1% nonidet P-40, 100 mg/ml leupeptin, 10 mg/ml pepstatin, 1 mM PMSF, 20 mM NaF, 2 mM Na 3 VO 4 , and 5 nM microcystin (Sigma). Lamin B was immunoprecipitated using rabbit antilamin B antibody (Dr N Chaudhary) and protein A/G sepharose beads (Santa Cruz). The precipitate separated on a 10% SDS-polyacrylamide gel. The gels were then dried and exposed to pre-¯ashed autoradiography ®lm (Kodak, Xomat-LS).
In vitro phosphorylation of lamin B and lamin B sequence peptides Lamin B immunoprecipitated from 2610 6 healthy HL60 cells, or peptides containing the human lamin B sequence for residues 389 ± 410 (KLSPSPSSRVTVSRASSSRSVR) and with S395A and S405A mutations, were incubated with 50 ng of recombinant human PKC-bll or PKC-d (Calbiochem-Novabiochem) in a lipid kinase assay system, exactly as previously described (Monks et al., 1997) . Labelled protein or peptides were separated on 10% SDS ± PAGE or 20% TrisTricine gels, respectively. Gels were dried and developed by autoradiography.
